LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,189,000 | +6.7% | 30,068 | +0.5% | 0.01% | 0.0% |
| Q2 2021 | $3,925,000 | -10.7% | 29,921 | +3.8% | 0.01% | -16.7% |
| Q1 2021 | $4,395,000 | -34.7% | 28,826 | -57.4% | 0.01% | -33.3% |
| Q4 2020 | $6,727,000 | +81.9% | 67,644 | +74.3% | 0.02% | +38.5% |
| Q3 2020 | $3,699,000 | -9.1% | 38,807 | +6.7% | 0.01% | -18.8% |
| Q2 2020 | $4,069,000 | +67.4% | 36,383 | +8.8% | 0.02% | +23.1% |
| Q1 2020 | $2,431,000 | -2.3% | 33,426 | +40.2% | 0.01% | 0.0% |
| Q4 2019 | $2,487,000 | +328.8% | 23,847 | +309.0% | 0.01% | +333.3% |
| Q3 2019 | $580,000 | -12.9% | 5,831 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $666,000 | +85.5% | 5,831 | +104.3% | 0.00% | +100.0% |
| Q1 2019 | $359,000 | – | 2,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |